Emcure Pharmaceuticals has announced the re-appointment of Dr. Shailesh Kripalu Ayyangar, Mr. Vijay Keshav Gokhale, and Dr. Vidya Rajiv Yeravdekar as Independent Directors. The re-appointments, approved on February 4, 2026, are for second consecutive terms, subject to shareholder approval. Their tenures will begin in April and June 2026, bringing continuity and experience to the company’s board.
Independent Director Re-appointments
The Board of Directors at Emcure Pharmaceuticals approved the re-appointment of three Independent Directors during their meeting on February 4, 2026. These re-appointments are for a second consecutive term and are pending shareholder approval.
Director Details
Dr. Shailesh Kripalu Ayyangar will serve another five-year term starting June 2, 2026. He has over 40 years of experience in the healthcare industry.
Mr. Vijay Keshav Gokhale will also serve a further five-year term commencing on April 16, 2026. Mr. Gokhale has extensive experience in foreign service, including postings as Ambassador of India to Germany and China.
Dr. Vidya Rajiv Yeravdekar has been re-appointed for a second consecutive term of three years, effective from April 16, 2026. Dr. Yeravdekar is the Principal Director of Symbiosis Society.
Source: BSE
